ACM
TXG icon

Aquatic Capital Management’s 10x Genomics TXG Stock Holding History

Aquatic Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,884
Closed -$525K – 1786
2025
Q3 		$525K Buy
+44,884
New +$585K 0.01% 862
2025
Q2 		– Sell
-180,255
Closed -$1.57M – 1555
2025
Q1 		$1.57M Buy
180,255
+51,226
+40% +$646K 0.04% 477
2024
Q4 		$1.85M Buy
+129,029
New +$2.04M 0.05% 393
2024
Q1 		– Sell
-200
Closed -$11K – 1659
2023
Q4 		$11K Sell
200
-28,900
-99% -$1.26M ﹤0.01% 1258
2023
Q3 		$1.2M Buy
29,100
+16,600
+133% +$864K 0.05% 299
2023
Q2 		$698K Buy
12,500
+3,400
+37% +$184K 0.04% 377
2023
Q1 		$508K Sell
9,100
-7,100
-44% -$332K 0.03% 412
2022
Q4 		$591K Buy
+16,200
New +$530K 0.04% 460

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aquatic Capital Management's TXG Position: Q4 2025 in Review

Aquatic Capital Management sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 44,884 shares — an estimated $525K sold.

Aquatic Capital Management first reported a position in TXG in Q4 2022 and held it in 8 quarters. The position peaked at $1.85M in Q4 2024. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Aquatic Capital Management reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 44,884 10x Genomics shares in Q4 2025, an estimated $525K.
  • Aquatic Capital Management first reported a position in 10x Genomics in Q4 2022 and held it in 8 quarters.
  • Aquatic Capital Management's 10x Genomics position peaked at $1.85M in Q4 2024.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.